Pieter Jelle Visser

Summary

Publications

  1. pmc Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study
    Ron L H Handels
    Alzheimer Centre Limburg, School for Mental Health and NeuroScience MHeNS, University Medical Centre, P O Box 5800, 6202, AZ Maastricht, The Netherlands
    BMC Neurol 12:72. 2012
  2. doi request reprint Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands
    Alzheimers Dement 8:560-3. 2012
  3. doi request reprint Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
    Stephanie J B Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    Neurology 80:1124-32. 2013
  4. doi request reprint Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment
    Lies Clerx
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    Neurobiol Aging 34:2003-13. 2013
  5. pmc Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
    Stephanie Jb Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands Electronic address
    Lancet Neurol 12:957-65. 2013
  6. doi request reprint Progression to dementia in memory clinic patients without dementia: a latent profile analysis
    Sebastian Kohler
    From the Alzheimer Center Limburg S K, R H, P J V, P A, F R J V, I R, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht and Alzheimer Center and Department of Neurology N S, Y A L P, W M v d F, P S, P J V, Department of Medical Psychology T K, Neuroscience Campus Amsterdam, and Department Epidemiology and Biostatistics W M v d F, VU University Medical Center, Amsterdam, The Netherlands
    Neurology 81:1342-9. 2013
  7. doi request reprint Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
    Stephanie Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    Neurobiol Aging 33:2272-81. 2012
  8. doi request reprint The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study
    Angelique P A Vermeiren
    Caphri, Department of Social Medicine, Maastricht University, Maastricht, The Netherlands
    J Alzheimers Dis 35:241-6. 2013
  9. doi request reprint The predictive value of memory strategies for Alzheimer's disease in subjects with mild cognitive impairment
    Inez H G B Ramakers
    Department of Psychiatry and Neuropsychology Alzheimer Center Limburg, School for Mental Health and Neurosciences, Maastricht University Medical Center, Maastricht, The Netherlands
    Arch Clin Neuropsychol 25:71-7. 2010
  10. doi request reprint Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, University of Maastricht, 6200 MD Maastricht, Netherlands
    Lancet Neurol 8:619-27. 2009

Collaborators

Detail Information

Publications22

  1. pmc Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study
    Ron L H Handels
    Alzheimer Centre Limburg, School for Mental Health and NeuroScience MHeNS, University Medical Centre, P O Box 5800, 6202, AZ Maastricht, The Netherlands
    BMC Neurol 12:72. 2012
    ....
  2. doi request reprint Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands
    Alzheimers Dement 8:560-3. 2012
    ..Further research is needed to validate the criteria. Modifications are likely to be made before the criteria can be used in daily practice...
  3. doi request reprint Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
    Stephanie J B Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    Neurology 80:1124-32. 2013
    ....
  4. doi request reprint Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment
    Lies Clerx
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    Neurobiol Aging 34:2003-13. 2013
    ..MTA-score and lateral ventricle volume correlated with CSF beta-amyloid 1-42. We can conclude that volumetric hippocampal measurements are the best predictors of AD conversion in subjects with MCI...
  5. pmc Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
    Stephanie Jb Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands Electronic address
    Lancet Neurol 12:957-65. 2013
    ..We aimed to investigate the prevalence and long-term outcome of preclinical Alzheimer's disease according to these criteria...
  6. doi request reprint Progression to dementia in memory clinic patients without dementia: a latent profile analysis
    Sebastian Kohler
    From the Alzheimer Center Limburg S K, R H, P J V, P A, F R J V, I R, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht and Alzheimer Center and Department of Neurology N S, Y A L P, W M v d F, P S, P J V, Department of Medical Psychology T K, Neuroscience Campus Amsterdam, and Department Epidemiology and Biostatistics W M v d F, VU University Medical Center, Amsterdam, The Netherlands
    Neurology 81:1342-9. 2013
    ..To identify the existence of discrete cognitive subtypes among memory clinic patients without dementia and test their prognostic values...
  7. doi request reprint Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
    Stephanie Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    Neurobiol Aging 33:2272-81. 2012
    ..These results provide further support for the use of CSF and magnetic resonance imaging biomarkers to identify prodromal AD...
  8. doi request reprint The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study
    Angelique P A Vermeiren
    Caphri, Department of Social Medicine, Maastricht University, Maastricht, The Netherlands
    J Alzheimers Dis 35:241-6. 2013
    ..81, 95% CI 0.38-1.72, n = 183). This suggests that mechanisms in developing Alzheimer-type dementia may differ between educational groups that raises questions related to Alzheimer-type dementia prevention...
  9. doi request reprint The predictive value of memory strategies for Alzheimer's disease in subjects with mild cognitive impairment
    Inez H G B Ramakers
    Department of Psychiatry and Neuropsychology Alzheimer Center Limburg, School for Mental Health and Neurosciences, Maastricht University Medical Center, Maastricht, The Netherlands
    Arch Clin Neuropsychol 25:71-7. 2010
    ..Prodromal AD is characterized by a decreased use of effortful learning strategies. This finding may have implications for the early detection of AD in MCI subjects and for the development of cognitive training programs...
  10. doi request reprint Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, University of Maastricht, 6200 MD Maastricht, Netherlands
    Lancet Neurol 8:619-27. 2009
    ..We investigated the prevalence of a CSF AD profile in patients with SCI, naMCI, or aMCI and the association of this profile with cognitive outcome in each group...
  11. doi request reprint Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis
    Lyzel S Elias-Sonnenschein
    School of Mental Health and Neuroscience, Alzheimer Center Limburg, Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, Maastricht, The Netherlands
    J Neurol Neurosurg Psychiatry 82:1149-56. 2011
    ..The APOE-ε4 allele is the strongest known genetic risk factor for AD. The authors performed a meta-analysis to establish the predictive accuracy of the APOE-ε4 allele for progression from MCI to AD-type dementia...
  12. pmc Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort
    Lyzel S Elias-Sonnenschein
    Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands
    PLoS ONE 8:e59676. 2013
    ....
  13. pmc Injury markers predict time to dementia in subjects with MCI and amyloid pathology
    Ineke A van Rossum
    Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
    Neurology 79:1809-16. 2012
    ..However, little is known about the rate of decline in those subjects. In this cohort study, we aimed to assess the conversion rate to dementia and identify prognostic markers in subjects with MCI and evidence of amyloid pathology...
  14. pmc Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice
    Stephanie J B Vos
    Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands
    PLoS ONE 9:e100784. 2014
    ..Cerebrospinal fluid (CSF) biomarkers are increasingly being used for diagnosis of Alzheimer's disease (AD)...
  15. doi request reprint Characteristics of help-seeking behaviour in subjects with subjective memory complaints at a memory clinic: a case-control study
    Inez H G B Ramakers
    Department of Psychiatry and Neuropsychology, Institute of Brain and Behaviour, Maastricht University, The Netherlands
    Int J Geriatr Psychiatry 24:190-6. 2009
    ..Only a subset of these subjects seeks medical attention for these complaints. The aim of the present study was to investigate which factors determine why people with subjective memory complaints (SMC) seek medical attention...
  16. doi request reprint New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements
    Lies Clerx
    Alzheimer Centre Limburg, School for Mental Health and NeuroScience MHeNS, University Medical Centre, Maastricht, The Netherlands
    J Alzheimers Dis 29:405-29. 2012
    ..Furthermore, it seems that MD values have somewhat more discriminative power than FA values with higher ES in the frontal, parietal, occipital and temporal lobe...
  17. doi request reprint Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
    Heidi I L Jacobs
    Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centre, Limburg, Maastricht University, Maastricht, The Netherlands
    Neurobiol Aging 33:201.e1-8. 2012
    ....
  18. ncbi request reprint Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis
    Inez H G B Ramakers
    Department of Psychiatry and Neuropsychology, Institute of Brain and Behavior, Maastricht University, Maastricht, The Netherlands
    Dement Geriatr Cogn Disord 24:300-6. 2007
    ..To investigate which symptoms are indicative of preclinical dementia in general practice and whether subjects with preclinical dementia have an increased contact frequency with their general practitioner (GP)...
  19. doi request reprint Relationship between genetic risk factors and markers for Alzheimer's disease pathology
    Lyzel S Elias-Sonnenschein
    School for Mental Health and Neuroscience, Alzheimer Centrum Limburg, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands
    Biomark Med 6:477-95. 2012
    ..Of all covered genes, only APOE and PICALM showed consistent effects on Aβ but not on tau, while no obvious effects were observed for CLU, CR1, ACE, SORL and MAPT...
  20. ncbi request reprint Ten-year risk of dementia in subjects with mild cognitive impairment
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands
    Neurology 67:1201-7. 2006
    ..To investigate the 10-year risk of dementia in subjects with mild cognitive impairment (MCI) ages 40 to 85 years...
  21. ncbi request reprint MCI is not a clinically useful concept
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands
    Int Psychogeriatr 18:402-9; discussion 409-14. 2006
  22. ncbi request reprint Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects
    Pieter Jelle Visser
    Department of Psychiatry and Neuropsychology, Institute of Brain and Behaviour, University of Maastricht, The Netherlands
    J Neurol 249:312-9. 2002
    ..Step-wise scoring of the PAS can reduce the number of elaborate or expensive diagnostic procedures considerably...